GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

GRACEcast - Discussions with the Global Resource for Advancing Cancer Education

In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums

Episodes

Barriers to Biomarker Testing: Ordering Tests

April 20, 2024 • 6 mins
Dr. Aakash Desai emphasizes the importance of physicians ordering biomarker testing for patients with NSCLC
Mark as Played

The Adaura Trial: The Effect on EGFR+ Treatment

April 15, 2024 • 6 mins
Dr. Joshua Reuss discusses the ADAURA trial, which suggested Osimertinib as treatment for EGFR+ NSCLC.
Mark as Played

Biomarker Driven Therapy for NSCLC

April 13, 2024 • 5 mins
Dr. Aakash Desai discusses the administration of therapy for biomarkers, and how to overcome the gaps in administration, access, and affordability.
Mark as Played

Current Recommendations and Best Practices for Biomarker Testing

April 11, 2024 • 3 mins
Dr. Aakash Desai discusses the current recommendations for biomarker testing in patients with NSCLC, as well as best practices.
Mark as Played

The Importance of Biomarker Testing: What is Liquid Biopsy?

April 9, 2024 • 4 mins
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
Mark as Played

Biomarkers in NSCLC

April 9, 2024 • 5 mins
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.
Mark as Played

Key Points from the Adaura Trial: Osimertinib

November 30, 2023 • 6 mins
Dr. Joshua Reuss examines important details learned during the ADAURA trial, including overall survival, reduced risk of brain mets, and side effects.
Mark as Played

Biomarkers in NSCLC

November 23, 2023 • 5 mins
Dr. Aakash Desai gives a basic overview of biomarkers, and discusses which ones are important for patients with NSCLC.
Mark as Played

The Importance of Biomarker Testing: What is Liquid Biopsy?

November 16, 2023 • 4 mins
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
Mark as Played

Barriers to Biomarker Testing: Cost and Insurance

November 10, 2023 • 3 mins
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
Mark as Played

Neoadjuvant Treatment for Patients with NSCLC

October 27, 2023 • 3 mins
Dr. Joshua Reuss examines data on neoadjuvant targeted therapy.
Mark as Played

The Alina Trial for ALK+ NSCLC

October 21, 2023 • 1 min
Dr. Joshua Reuss gives a brief description of the ongoing Alina trial for patients with ALK+ NSCLC.
Mark as Played

Local Therapy for Limited Metastatic NSCLC

October 17, 2023 • 4 mins
Dr. Puneeth Iyengar discusses the concept of using local therapy as an additional treatment for limited metastatic NSCLC, including Stereotactic Body Radiation Therapy (SBRT).
Mark as Played

Immunotherapy for Patients with Resectable NSCLC and a Driver Mutation

October 10, 2023 • 2 mins
Dr. Joshua Reuss explains why immunotherapy is not typically given to patients with resectable NSCLC and a driver mutation.
Mark as Played

Treatment Options for Patients with Locally Advanced Unresectable NSCLC

October 3, 2023 • 1 min
Dr. Joshua Reuss discusses treatment options for patients with locally advanced NSCLC, and how to proceed while waiting for trial data.
Mark as Played

Local Therapy for NSCLC Patients After Frontline Therapy

September 27, 2023 • 7 mins
Dr. Puneeth Iyengar discusses local therapy options for patients with metastatic disease who have received a front line therapy.
Mark as Played

The Role of the Patient as Advocate

September 24, 2023 • 2 mins
Dr. Joshua Reuss discusses what the patient can do to advocate for themselves during treatment.
Mark as Played

Targeted Therapy Before Surgery in Patients with Resectable NSCLC and Driver Mutation

September 20, 2023 • 3 mins
Dr. Joshua Reuss discusses considerations and questions for targeted therapy before surgery.
Mark as Played

Local Therapy for Patients with Oligoprogressive NSCLC

September 15, 2023 • 5 mins
Dr. Puneeth Iyengar discusses local therapy treatment options for patients who have oligoprogressive disease.
Mark as Played

The Future of Local Therapy in Lung Cancer

September 14, 2023 • 2 mins
Dr. Puneeth Iyengar examines what has been learned from studies, what still remains unanswered, and future directions of local therapy treatments for patients with NSCLC.
Mark as Played

Popular Podcasts

    Dateline NBC

    Dateline NBC

    Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations.

    Death, Sex & Money

    Death, Sex & Money

    Anna Sale explores the big questions and hard choices that are often left out of polite conversation.

    Stuff You Should Know

    Stuff You Should Know

    If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.

    Crime Junkie

    Crime Junkie

    If you can never get enough true crime... Congratulations, you’ve found your people.

    Start Here

    Start Here

    A straightforward look at the day's top news in 20 minutes. Powered by ABC News. Hosted by Brad Mielke.

Advertise With Us
Music, radio and podcasts, all free. Listen online or download the iHeart App.

Connect

Explore

iHeart

Live Radio

Podcasts

Artist Radio

Exclusives

News

Features

Events

Contests

Photos

Information

About

Advertise

Blog

Brand Guidelines

Contest Guidelines

Subscription Offers

Jobs

Get the App

Automotive

Home

Mobile

Wearables

© 2024 iHeartMedia, Inc.